Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4-5 Chronic Kidney Disease or on Dialysis.

Chen, Chen; Cao, Yalin; Zheng, Ying; Dong, Yugang; Ma, Jianyong; Zhu, Wengen; Liu, Chen

Chen, Chen; Cao, Yalin; Zheng, Ying; Dong, Yugang; Ma, Jianyong; Zhu, Wengen; Liu, Chen.

Affiliation

Chen C; Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Cao Y; NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.
Zheng Y; National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, Guangzhou, People's Republic of China.
Dong Y; Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang, 550001, People's Republic of China.
Ma J; Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Zhu W; Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Liu C; NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.

Cardiovasc Drugs Ther ; 35(2): 273-281, 2021 04.

Article in En | MEDLINE | ID: mdl-33538928

Subject(s)
Key words

Anticoagulants; Atrial fibrillation; Outcome; Renal insufficiency

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Renal Dialysis / Renal Insufficiency, Chronic / Anticoagulants Type of study: Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: Cardiovasc Drugs Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google